Arcellx, Inc. Profile Avatar - Palmy Investing

Arcellx, Inc.

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical tr…
Biotechnology
US, Gaithersburg [HQ]
Competitors · Subsidiaries · Locations

Context Analysis

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Competitors Table
Competitor Private? Source Accuracy Country City
Nuvalent, Inc. FMP High United States Cambridge
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of ACLX's Analysis
CIK: 1786205 CUSIP: 03940C100 ISIN: US03940C1009 LEI: - UEI: -
Secondary Listings
ACLX has no secondary listings inside our databases.